Streptozotocin and alloxan-based selection improves toxin resistance of insulin-producing RINm cells

Experimental Diabesity Research

Volumn 1, Issue 3, 2000, Pages 211-219

  Bloch, Konstantin O ^a   Zemel, Romy ^b   Bloch, Olga V ^c   Grief, Hagar ^b   Vardi, Pnina ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

3 O methyl glucose; Alloxan; GLUT 2; Insulin; RIN cells; Streptozotocin

Indexed keywords

3 METHYLGLUCOSE; ALLOXAN; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 2; HYDROGEN PEROXIDE; INSULIN; STREPTOZOCIN; THYMIDINE;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; CELL SURVIVAL; COMPARATIVE STUDY; DRUG EFFECT; DRUG RESISTANCE; INSULINOMA; METABOLISM; PANCREAS TUMOR; RAT; SECRETION;

3-O-METHYLGLUCOSE; ALLOXAN; ANALYSIS OF VARIANCE; ANIMALS; CELL DIVISION; CELL SURVIVAL; DRUG RESISTANCE; GLUCOSE TRANSPORTER TYPE 2; HYDROGEN PEROXIDE; INSULIN; INSULINOMA; MONOSACCHARIDE TRANSPORT PROTEINS; PANCREATIC NEOPLASMS; RATS; STREPTOZOCIN; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 0034570756     PISSN: 15438600     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/edr.2000.211     Document Type: Article

References (18)

1. Newgard, C. B. (1994). Cellular engineering and gene therapy strategies for insulin replacement in diabetes, Diabetes, 43, 341-350.
2. Efrat, S. (1998). Cell-based therapy for insulin-dependent diabetes mellitus, Eur. J. Endocrinol., 138, 129-133.
3. Gazdar, A. F., Chick, W. L., Oie, H. K., Sims, H. L., King, D. L., Weir, G. C. and Lauris, V. (1980). Continuous, clonal, insulin- and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor, Proc. Natl. Acad. Sci. USA, 77, 3519-3523.
4. Okamoto, H. (1996). Okamoto model for B-cell damage: recent advances, In: Lessons from animal diabetes, edited by Shafrir, E. pp. 97-112, Boston, Birkhauser.
5. Lenzen, S. and Panten, U. (1988). Alloxan: history and mechanism of action, Diabetologia, 31, 337-342.
6. Weiss, R. B. (1982). Streptozotocin: a review of its pharmacology, efficacy, and toxicity, Cancer Treat Rep., 66, 427-438.
7. Schnedl, W. J., Ferber, S., Johnson, J. H. and Newgard, C. B. (1994). STZ transport and cytotoxicity. Specific enhancement in GLUT-2-expressing cells, Diabetes, 43, 1326-1333.
8. Munday, R., Ludwig, K. and Lenzen, S. (1993). The relationship between the physicochemical properties and the biological effects of alloxan and several N-alkyl substituted alloxan derivatives, J. Endocrinol., 139, 153-163.
9. Tiege, M., Lortz, S., Drinkgern, J. and Lenzen, S. (1997). Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells, Diabetes, 46, 1733-1742.
10. Fernandes, A., King, L. C., Guz, Y., Stein, R., Wright, C. V. E. and Teitelman, G. (1997). Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets, Endocrinology, 138, 1750-1762.
11. Eizirik, D. L., Pipeleers, D. G., Ling, Z., Welsh, N., Hellerstrom, C. and Andersson, A. (1994). Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury, Proc. Natl. Acad. Sci. USA, 91, 9253-9256.
12. De Vos, A., Heimberg, H., Quartier, E., Huypens, P., Bouwens, L., Pipeleers, D. and Schuit, F. (1995). Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression, J. Clin. Invest., 96, 2489-2495.
13. Pipeleers, D., Kiekens, R., Ling, Z., Wilikens, A. and Schuit, F. (1994). Physiologic relevance of heterogeneity in the pancreatic beta-cell population, Diabetologia, 37 (Suppl. 2), S57-S64.
14. Janjic, D. and Wollheim, C. B. (1992). Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetric assay, Diabetologia, 35, 482-485.
15. McClenaghan, N. H., Barnet, C. R., Ah-Sing, E., Abdel-Wahab, Y. H. A., O'Harte, F. P. M., Yoon, T. W., Swanston-Flatt, S. K. and Flatt, P. R. (1996). Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion, Diabetes, 45, 1132-1140.
16. Thorens, B., Sarkar, H. K., Kaback, H. R. and Lodish, H. F. (1988). Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells, Cell, 55, 281-290.
17. Wang, Z. and Gleichmann, H. (1998). GLUT-2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice, Diabetes, 47, 50-56.
18. White, J. W., Swartz, F. J. and Swartz, A. F. (1985). Excess glucose intake induces accelerated beta-cell polyploidization in normal mice: a possible deleterious effect, J. Nutr., 115, 271-278.